Hc Advisors, LLC Pfizer Inc Transaction History

Hc Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $213,927 - $265,082	-4,676 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $12,602 - $18,681	-305 Reduced 6.12%	4,676 $276,000
Q3 2021 Oct 29, 2021	SELL	$39.25 - $50.42 $36,816 - $47,293	-938 Reduced 15.85%	4,981 $214,000
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $179,262 - $203,074	-4,992 Reduced 45.75%	5,919 $232,000
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $7,602 - $8,573	227 Added 2.12%	10,911 $395,000
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $47,795 - $60,775	-1,428 Reduced 11.79%	10,684 $393,000
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $299,910 - $351,863	-9,446 Reduced 43.82%	12,112 $445,000
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $649,326 - $787,729	21,558 New	21,558 $705,000
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $421,586 - $602,356	-15,597 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $513,453 - $582,703	15,597 New	15,597 $611,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hc Advisors, LLC with notifications on news.